ExodusPoint Capital Management, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$109,000
+101.9%
16,198
+26.8%
0.00%0.0%
Q2 2021$54,00012,7720.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 3,135,289$46,246,0005.88%
GREAT POINT PARTNERS LLC 2,006,211$29,592,0005.76%
Lyon Street Capital, LLC 463,064$6,830,0002.63%
SENZAR ASSET MANAGEMENT, LLC 335,445$4,948,0001.21%
INGALLS & SNYDER LLC 1,209,062$17,834,0000.93%
Senvest Management, LLC 314,629$4,641,0000.31%
KNOTT DAVID M 45,000$664,0000.28%
DRIEHAUS CAPITAL MANAGEMENT LLC 262,569$3,873,0000.15%
PRINCETON CAPITAL MANAGEMENT INC 14,607$215,0000.11%
Manchester Capital Management LLC 19,984$295,0000.05%
View complete list of CONCERT PHARMACEUTICALS INC shareholders